Breakthrough drugs are getting harder to find. Where do we look, now? One of the most promising and least explored is insects. Why do scientists expect insect-derived compounds to have a broad impact on healthcare? Which insect families are most promising? And, how will the industry scale-up production of these compounds to commercial levels? We’ll provide the answers.
- Business Moves Beyond Economies of Scale
- Climate Alarmists: “We don’t need no stinking facts”